Abstract
Generalized social anxiety disorder (GSAD) is characterized by aberrant patterns of amygdala-frontal connectivity to social signals of threat and at rest. The neuropeptide oxytocin (OXT) modulates anxiety, stress, and social behaviors. Recent functional neuroimaging studies suggest that these effects are mediated through OXT’s effects on amygdala reactivity and/or amygdala-frontal connectivity. The aim of the current study was to examine OXT’s effects on amygdala-frontal resting-state functional connectivity (rsFC) in GSAD patients and healthy controls (HCs). In a randomized, double-blind, cross-over design, 18 GSAD and 18 HC participants received intranasal OXT (24 IU or 40.32 μg) or placebo (PBO) before resting-state functional magnetic resonance imaging. In individuals with GSAD, OXT enhanced rsFC of the left and right amygdala with rostral anterior cingulate cortex (ACC)/medial prefrontal cortex (mPFC), and in doing so, reversed (ie, ‘normalized’) the reduced amygdala-frontal connectivity observed relative to HCs evident on PBO. Higher social anxiety severity in GSAD subjects correlated with lower amygdala-ACC/mPFC connectivity on PBO and higher social anxiety also correlated with greater enhancement in amygdala-frontal connectivity induced by OXT. These findings show that OXT modulates a neural circuit known for social threat processing and emotion regulation, suggesting a neural mechanism by which OXT may have a role in the pathophysiology and treatment of social anxiety disorder.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Adolphs R (2009). The social brain: neural basis of social knowledge. Annu Rev Psychol 60: 693–716.
Amir N, Klumpp H, Elias J, Bedwell JS, Yanasak N, Miller LS (2005). Increased activation of the anterior cingulate cortex during processing of disgust faces in individuals with social phobia. Biol Psychiatry 57: 975–981.
Banks SJ, Eddy KT, Angstadt M, Nathan PJ, Phan KL (2007). Amygdala-frontal connectivity during emotion regulation. Soc Cogn Affect Neurosci 2: 303–312.
Bartz JA, Zaki J, Bolger N, Ochsner KN (2011). Social effects of oxytocin in humans: context and person matter. Trends Cogn Sci 15: 301–309.
Beck AT, Steer RA, Ball R, Ranieri WF (1996). Comparison of Beck Depression Inventories-IA and-II in psychiatric outpatients. J Pers Assess 67: 588–597.
Behzadi Y, Restom K, Liau J, Liu TT (2007). A component based noise correction method (CompCor) for BOLD and perfusion based fMRI. Neuroimage 37: 90–101.
Bethlehem RA, van Honk J, Auyeung B, Baron-Cohen S (2013). Oxytocin, brain physiology, and functional connectivity: a review of intranasal oxytocin fMRI studies. Psychoneuroendocrinology 38: 962–974.
Bielsky IF, Young LJ (2004). Oxytocin, vasopressin, and social recognition in mammals. Peptides 25: 1565–1574.
Bishop SJ, Duncan J, Lawrence AD (2004). State anxiety modulation of the amygdala response to unattended threat-related stimuli. J Neurosci 24: 10364–10368.
Carter CS, Grippo AJ, Pournajafi-Nazarloo H, Ruscio MG, Porges SW (2008). Oxytocin, vasopressin and sociality. Prog Brain Res 170: 331–336.
Davidson RJ, Marshall JR, Tomarken AJ, Henriques JB (2000). While a phobic waits: regional brain electrical and autonomic activity in social phobics during anticipation of public speaking. Biol Psychiatry 47: 85–95.
Domes G, Heinrichs M, Gläscher J, Büchel C, Braus DF, Herpertz SC (2007). Oxytocin attenuates amygdala responses to emotional faces regardless of valence. Biol Psychiatry 62: 1187–1190.
Domes G, Lischke A, Berger C, Grossmann A, Hauenstein K, Heinrichs M et al (2010). Effects of intranasal oxytocin on emotional face processing in women. Psychoneuroendocrinology 35: 83–93.
Ehrlich I, Humeau Y, Grenier F, Ciocchi S, Herry C, Lüthi A (2009). Amygdala inhibitory circuits and the control of fear memory. Neuron 62: 757–771.
Etkin A, Egner T, Peraza DM, Kandel ER, Hirsch J (2006). Resolving emotional conflict: a role for the rostral anterior cingulate cortex in modulating activity in the amygdala. Neuron 51: 871–882.
Etkin A, Schatzberg AF (2011). Common abnormalities and disorder-specific compensation during implicit regulation of emotional processing in generalized anxiety and major depressive disorders. Am J Psychiatry 168: 968–978.
Evans KC, Simon NM, Dougherty DD, Hoge EA, Worthington JJ, Chow C et al (2009). A PET study of tiagabine treatment implicates ventral medial prefrontal cortex in generalized social anxiety disorder. Neuropsychopharmacology 34: 390–398.
Evans KC, Wright CI, Wedig MM, Gold AL, Pollack MH, Rauch SL (2008). A functional MRI study of amygdala responses to angry schematic faces in social anxiety disorder. Depress Anxiety 25: 496–505.
Farmer C, Thurm A, Grant P (2013). Pharmacotherapy for the core symptoms in autistic disorder: current status of the research. Drugs 73: 303–314.
Fox MD, Raichle ME (2007). Spontaneous fluctuations in brain activity observed with functional magnetic resonance imaging. Nat Rev Neurosci 8: 700–711.
Ghashghaei HT, Hilgetag CC, Barbas H (2007). Sequence of information processing for emotions based on the anatomic dialogue between prefrontal cortex and amygdala. Neuroimage 34: 905–923.
Gimpl G, Fahrenholz F (2001). The oxytocin receptor system: structure, function, and regulation. Physiol Rev 81: 629–683.
Goldin PR, Manber T, Hakimi S, Canli T, Gross JJ (2009). Neural bases of social anxiety disorder: emotional reactivity and cognitive regulation during social and physical threat. Arch Gen Psychiatry 66: 170–180.
Goldin PR, Ziv M, Jazaieri H, Hahn K, Heimberg R, Gross JJ (2013). Impact of cognitive behavioral therapy for social anxiety disorder on the neural dynamics of cognitive reappraisal of negative self-beliefs: randomized clinical trial. JAMA Psychiatry 70: 1048–1056.
Guastella AJ, Howard AL, Dadds MR, Mitchell P, Carson DS (2009). A randomized controlled trial of intranasal oxytocin as an adjunct to exposure therapy for social anxiety disorder. Psychoneuroendocrinology 34: 917–923.
Hahn A, Stein P, Windischberger C, Weissenbacher A, Spindelegger C, Moser E et al (2011). Reduced resting-state functional connectivity between amygdala and orbitofrontal cortex in social anxiety disorder. Neuroimage 56: 881–889.
Huber D, Veinante P, Stoop R (2005). Vasopressin and oxytocin excite distinct neuronal populations in the central amygdala. Science 308: 245–248.
Kim MJ, Loucks RA, Palmer AL, Brown AC, Solomon KM, Marchante AN et al (2011). The structural and functional connectivity of the amygdala: from normal emotion to pathological anxiety. Behav Brain Res 223: 403–410.
Kirsch P, Esslinger C, Chen Q, Mier D, Lis S, Siddhanti S et al (2005). Oxytocin modulates neural circuitry for social cognition and fear in humans. J Neurosci 25: 11489–11493.
Klumpp H, Angstadt M, Phan KL (2012). Insula reactivity and connectivity to anterior cingulate cortex when processing threat in generalized social anxiety disorder. Biol Psychol 89: 273–276.
Klumpp H, Fitzgerald DA, Phan KL (2013a). Neural predictors and mechanisms of cognitive behavioral therapy on threat processing in social anxiety disorder. Prog Neuropsychopharmacol Biol Psychiatry 45: 83–91.
Klumpp H, Post D, Angstadt M, Fitzgerald DA, Phan KL (2013b). Anterior cingulate cortex and insula response during indirect and direct processing of emotional faces in generalized social anxiety disorder. Biol Mood Anxiety Disord 3: 7.
Labuschagne I, Phan KL, Wood A, Angstadt M, Chua P, Heinrichs M et al (2010). Oxytocin attenuates amygdala reactivity to fear in generalized social anxiety disorder. Neuropsychopharmacology 35: 2403–2413.
Labuschagne I, Phan KL, Wood A, Angstadt M, Chua P, Heinrichs M et al (2011). Medial frontal hyperactivity to sad faces in generalized social anxiety disorder and modulation by oxytocin. Int J Neuropsychopharmacol 1–14.
Liao W, Chen H, Feng Y, Mantini D, Gentili C, Pan Z et al (2010). Selective aberrant functional connectivity of resting state networks in social anxiety disorder. Neuroimage 52: 1549–1558.
Lieberman MD, Cunningham WA (2009). Type I and Type II error concerns in fMRI research: re-balancing the scale. Soc Cogn Affect Neurosci 4: 423–428.
Liebowitz MR (1987). Social phobia. Mod Probl Pharmacopsychiatry 22: 141–173.
Petrovic P, Kalisch R, Singer T, Dolan RJ (2008). Oxytocin attenuates affective evaluations of conditioned faces and amygdala activity. J Neurosci 28: 6607–6615.
Phan KL, Coccaro EF, Angstadt M, Kreger KJ, Mayberg HS, Liberzon I et al (2013). Corticolimbic brain reactivity to social signals of threat before and after sertraline treatment in generalized social phobia. Biol Psychiatry 73: 329–336.
Phan KL, Fitzgerald DA, Nathan PJ, Tancer ME (2006). Association between amygdala hyperactivity to harsh faces and severity of social anxiety in generalized social phobia. Biol Psychiatry 59: 424–429.
Prater KE, Hosanagar A, Klumpp H, Angstadt M, Phan KL (2013). Aberrant amygdala-frontal cortex connectivity during perception of fearful faces and at rest in generalized social anxiety disorder. Depress Anxiety 30: 234–241.
Spielberger CD (1983) Manual for the State-Trait Anxiety Inventory (form Y). Consulting Psychologists Press: Palo Alto, CA.
Sripada CS, Phan KL, Labuschagne I, Welsh R, Nathan PJ, Wood AG (2013). Oxytocin enhances resting-state connectivity between amygdala and medial frontal cortex. Int J Neuropsychopharmacol 16: 255–260.
Steer RA, Beck AT (1997). Beck anxiety inventory. Evaluating Stress: A Book of Resources. Scarecrow Press: Lanham, MD. PP 23–40.
Stein MB, Goldin PR, Sareen J, Zorrilla L, Brown GG (2002). Increased amygdala activation to angry and contemptuous faces in generalized social phobia. Arch Gen Psychiatry 59: 1027–1034.
Stein MB, Stein DJ (2008). Social anxiety disorder. Lancet 371: 1115–1125.
Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N et al (2002). Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 15: 273–289.
Viviani D, Charlet A, Burg E, van den, Robinet C, Hurni N, Abatis M et al (2011). Oxytocin selectively gates fear responses through distinct outputs from the central amygdala. Science 333: 104–107.
Viviani D, Stoop R (2008). Opposite effects of oxytocin and vasopressin on the emotional expression of the fear response. Prog Brain Res 170: 207–218.
Wager TD, Davidson ML, Hughes BL, Lindquist MA, Ochsner KN (2008). Prefrontal-subcortical pathways mediating successful emotion regulation. Neuron 59: 1037–1050.
Whitfield-Gabrieli S, Nieto-Castanon A (2012). Conn: a functional connectivity toolbox for correlated and anticorrelated brain networks. Brain Connect 2: 125–141.
World Health Organization (1997) Composite International Diagnostic Interview, Version 2.1. World Health Organization: Geneva, Switzerland.
Zink CF, Meyer-Lindenberg A (2012). Human neuroimaging of oxytocin and vasopressin in social cognition. Horm Behav 61: 400–409.
Acknowledgements
This research was funded by an Independent Investigator Award to PJN from the Brain and Behavior Research Foundation (formally National Alliance for Research in Schizophrenia and Depression [NARSAD]). AGW was supported by an Australian Rotary Health fellowship.
Author information
Authors and Affiliations
Corresponding author
PowerPoint slides
Rights and permissions
About this article
Cite this article
Dodhia, S., Hosanagar, A., Fitzgerald, D. et al. Modulation of Resting-State Amygdala-Frontal Functional Connectivity by Oxytocin in Generalized Social Anxiety Disorder. Neuropsychopharmacol 39, 2061–2069 (2014). https://doi.org/10.1038/npp.2014.53
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/npp.2014.53
This article is cited by
-
Connectome dysfunction in patients at clinical high risk for psychosis and modulation by oxytocin
Molecular Psychiatry (2024)
-
Prefrontal–amygdala circuits in social decision-making
Nature Neuroscience (2021)
-
Out-of-step: brain-heart desynchronization in anxiety disorders
Molecular Psychiatry (2021)
-
Molecular and neurocircuitry mechanisms of social avoidance
Cellular and Molecular Life Sciences (2021)
-
Effects of exogenous testosterone application on network connectivity within emotion regulation systems
Scientific Reports (2020)
